Cytomegalovirus Reactivation in Ulcerative Colitis Patients: Early Indicators
Authors:
Open Access
- 1 June 2023
- journal article
- research article
- Published by Medknow in Nigerian Journal of Clinical Practice
- Vol. 26 (6) , 765-770
Abstract
Background: The association of cytomegalovirus (CMV) infection with ulcerative colitis (UC) still remains a controversial topic for the clinicians. Aim: In this study, we aimed to elucidate the CMV infection related parameters in the exacerbation of UC. Material and Methods: In this study, 812 UC patients who have admitted to our institution between June 2008 and November 2020 were analyzed retrospectively. CMV infection was diagnosed by the detection of CMV DNA with polymerase chain reaction (PCR) in tissue biopsies with presence of clinical colitis symptoms. CMV negative UC patient group was defined as UC activation group with negative PCR results. Result: A total of 153 patients met the inclusion criteria during the study period, with a median age of 41.8 years. CMV PCR positivity had been detected in tissue biopsy in 43 (28.1%) UC patients. CMV-positive patients had a statistically significant higher frequency of steroid resistance, treatment with azathioprine, longer disease duration, longer remission, and hospitalization day. The mean C-reactive protein (CRP) level, platelet to lymphocyte ratio (PLR) were higher, and mean albumin level was lower in CMV positive patients, with statistically significance. Also, colectomy and anti-tumor necrosis factor-α (TNF-α) therapy were more frequent in CMV-reactivated group in long-term follow-up. In a multivariable model, steroid resistance, treatment with azathioprine, long disease duration, low albumin value was independently associated with colonic CMV infection. Conclusion: Steroid resistance, treatment with azathioprine, long disease duration, low albumin levels were significant risk factors for CMV colitis, among patients with UC activation.Keywords
This publication has 28 references indexed in Scilit:
- Review article: cytomegalovirus and inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2015
- A Model for Identifying Cytomegalovirus in Patients With Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2015
- Long-term follow-up of ulcerative colitis patients treated on the basis of their cytomegalovirus antigen statusWorld Journal of Gastroenterology, 2014
- The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central ChinaVirology Journal, 2013
- Cytomegalovirus (CMV)-Specific Perforin and Granzyme B ELISPOT Assays Detect Reactivation of CMV Infection in Inflammatory Bowel DiseaseCells, 2012
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2009
- Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFα therapyJournal of Clinical Virology, 2008
- Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel diseaseInflammatory Bowel Diseases, 2006
- Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcomeJournal of Medical Microbiology, 2004
- Cortisone in Ulcerative ColitisBMJ, 1955